Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 151-156

  Kang, Nam Hee ^a   Hwang, Kyung A ^a   Kim, Tae Hee ^b   Hyun, Sang Hwan ^a   Jeung, Eui Bae ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Cell cycle arrest; Cell proliferation; cyclin d1; cyclin dependent kinase 2; p21; Resveratrol

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; ENDOCRINE DISRUPTOR; ESTRADIOL; HEXABROMOCYCLODODECANE; METHOXYCHLOR; NONYLPHENOL; OCTYLPHENOL; PHENOL DERIVATIVE; PROTEIN P21; RESVERATROL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENDOCRINE DISRUPTORS; ESTRADIOL; FEMALE; HUMANS; OVARIAN NEOPLASMS; STILBENES;

VITACEAE;

EID: 84861643494     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.887     Document Type: Article

References (24)

1. Choi KC and Jeung EB: The biomarker and endocrine disruptors in mammals. J Reprod Dev 49: 337-345, 2003.
2. Park SH, Kim KY, An BS, Choi JH, Jeung EB, Leung PC and Choi KC: Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J Reprod Dev 55: 23-29, 2009.
3. Hwang KA, Park SH, Yi BR and Choi KC: Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res 27: 99-107, 2011.
4. Lee HR, Hwang KA, Park MA, Yi BR, Jeung EB and Choi KC: Treatment with bisphenol A and methoxychlor results in the growth of cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. Int J Mol Med 29: 883-890, 2012.
5. Park MA, Hwang KA, Lee HR, Yi BR, Jeung EB and Choi KC: Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes. Mol Med Report 5: 761-766, 2011.
6. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA and Berens ME: Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63: 280-288, 1989. (Pubitemid 19035019)
7. Yang G, Chang B, Yang F, Guo X, Cai KQ, Xiao XS, Wang H, Sen S, Hung MC, Mills GB, Chang S, Multani AS, Mercado-Uribe I and Liu J: Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res 16: 3171-3181, 2010.
8. Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J and Srivastava RK: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6: e16530, 2011.
9. Fremont L: Biological effects of resveratrol. Life Sci 66: 663-673, 2000.
10. Fukui M, Yamabe N and Zhu BT: Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo. Eur J Cancer 46: 1882-1891, 2010.
11. Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138: 619-620, 1998.
12. Roldan A, Palacios V, Caro I and Perez L: Resveratrol content of Palomino fino grapes: influence of vintage and fungal infection. J Agric Food Chem 51: 1464-1468, 2003.
13. Yi CO, Jeon BT, Shin HJ, Jeong EA, Chang KC, Lee JE, Lee DH, Kim HJ, Kang SS, Cho GJ, Choi WS and Roh GS: Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol 44: 194-203, 2011.
14. Kim KY, Yi BR, Lee HR, Kang NH, Jeung EB, Kim SU and Choi KC: Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use. Int J Oncol 40: 1097-1104, 2011.
15. Yi BR, Kang NH, Hwang KA, Kim SU, Jeung EB and Choi KC: Antitumor therapeutic effects of cytosine deaminase and interferon-beta against endometrial cancer cells using genetically engineered stem cells in vitro. Anticancer Res 31: 2853-2861, 2011.
16. Yi BR, O SN, Kang NH, Hwang KA, Kim SU, Jeung EB, Kim YB, Heo GJ and Choi KC: Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Int J Oncol 39: 833-839, 2011.
17. Kang NH, Yi BR, Lim SY, Hwang KA, Baek YS, Kang KS and Choi KC: Human amniotic membrane-derived epithelial stem cells display anticancer activity in BALB/c female nude mice bearing disseminated breast cancer xenografts. Int J Oncol: Feb, 2012 (E-pub ahead of print).
18. Hwang KA, Hwang YL, Lee MH, Kim NR, Roh SS, Lee Y, Kim CD, Lee JH and Choi KC: Adenosine stimulates growth of dermal papilla and lengthens the anagen phase by increasing the cysteine level via fibroblast growth factors 2 and 7 in an organ culture of mouse vibrissae hair follicles. Int J Mol Med 29: 195-201, 2011.
19. Shanle EK and Xu W: Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chem Res Toxicol 24: 6-19, 2011.
20. Lee MH, Choi BY, Kundu JK, Shin YK, Na HK and Surh YJ: Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res 69: 7449-7458, 2009.
21. Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, Sessa C and Vergote I: Ovarian cancer. Crit Rev Oncol Hematol 60: 159-179, 2006. (Pubitemid 44636248)
22. Roy SK, Chen Q, Fu J, Shankar S and Srivastava RK: Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One 6: e25166, 2011.
23. Vanamala J, Reddivari L, Radhakrishnan S and Tarver C: Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10: 238, 2010.
24. Liu D, Liu J, Lin B, Liu S, Hou R, Hao Y, Liu Q, Zhang S and Iwamori M: Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways. Int J Mol Sci 13: 828-839, 2012.